文献速递白血病淋巴瘤

表观遗传调控基因驱动MLL/AF4白血病谱系转换

Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia.
PubMed 文献 · Blood · 2022-01-01

MLL/AF4融合基因定义高危前B急性淋巴细胞白血病,复发可伴淋系向髓系转换。本研究显示髓系复发与配对淋系表现共享融合断点,起源于不同分化阶段,谱系转换与染色质可及性和转录程序重塑相关,CHD4等染色质修饰因子异常参与驱动。

要点

  • MLL/AF4白血病髓系复发与配对淋系表现共享致癌融合断点。
  • 谱系转换与染色质可及性及转录程序重塑相关。
  • CHD4等染色质修饰因子异常参与驱动和维持谱系转换。

核心结论

  • MLL/AF4白血病的谱系转换由表观遗传调控紊乱驱动和维持。

研究设计与样本

  • 本研究为实验研究,纳入MLL/AF4前B急性淋巴细胞白血病及其配对髓系复发样本。

主要发现

  • 髓系复发与配对淋系表现共享致癌融合断点,起源于从幼稚祖细胞到定向B细胞前体的不同分化阶段。
  • 谱系转换与染色质可及性显著改变及转录程序重塑相关,包括可变剪接。
  • 复发髓系表型反复与染色质修饰因子表达、剪接或突变改变相关,包括编码核小体重塑和去乙酰化复合物ATP酶/解旋酶的CHD4。

关键数值与推荐

  • CHD4单独或与其他突变表观遗传修饰因子联合扰动可在MLL/AF4+细胞模型中诱导髓系基因表达。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The fusion gene MLL/AF4 defines a high-risk subtype of pro-B acute lymphoblastic leukemia. Relapse can be associated with a lineage switch from acute lymphoblastic to acute myeloid leukemia, resulting in poor clinical outcomes caused by resistance to chemotherapies and immunotherapies. In this study, the myeloid relapses shared oncogene fusion breakpoints with their matched lymphoid presentations and originated from various differentiation stages from immature progenitors through to committed B-cell precursors. Lineage switching is linked to substantial changes in chromatin accessibility and rewiring of transcriptional programs, including alternative splicing. These findings indicate that the execution and maintenance of lymphoid lineage differentiation is impaired. The relapsed myeloid phenotype is recurrently associated with the altered expression, splicing, or mutation of chromatin modifiers, including CHD4 coding for the ATPase/helicase of the nucleosome remodelling and deacetylation complex. Perturbation of CHD4 alone or in combination with other mutated epigenetic modifiers induces myeloid gene expression in MLL/AF4+ cell models, indicating that lineage switching in MLL/AF4 leukemia is driven and maintained by disrupted epigenetic regulation.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Tirtakusuma R, Szoltysek K, Milne P, et al. Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia. Blood. 2022. PMID: 35839448. doi:10.1182/blood.2021015036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。